期刊文献+

丙泊酚或七氟醚复合舒芬太尼麻醉对CPB下瓣膜手术患者脑保护效应的比较 被引量:12

Cerebral protective effect of propofol versus sevoflurane combined with sufentanil anesthesia in patients undergoing valvular surgery under cardiopulmonary bypass
原文传递
导出
摘要 目的比较丙泊酚或七氟醚复合舒芬太尼麻醉对CPB下瓣膜手术患者的脑保护效应。方法择期CPB下行瓣膜手术患者60例,年龄60~70岁,ASA分级Ⅱ或Ⅲ级。采用随机数字表法分为丙泊酚复合麻醉组(PA组)和七氟醚复合麻醉组(SA组),每组30例。自麻醉诱导至术毕PA组持续靶控输注丙泊酚0.5—2.0μg/ml;SA组持续吸入0.5%~2.5%七氟醚,维持BIS值45—55。分别于麻醉诱导后即刻(T0)、术毕(T1)、术后6、12和24h(T2-4)时上腔静脉逆行置管抽取血样,采用ELISA法测定血浆S-100β蛋白和神经元特异性烯醇化酶(NSE)的浓度。结果与sA组比较,PA组T1,2时血浆S-100β蛋白浓度、T1-3时NSE浓度降低(P〈0.05)。结论丙泊酚复合舒芬太尼麻醉对CPB下瓣膜手术患者的脑保护效应优于七氟醚复合舒芬太尼麻醉。 Objective To compare the cerebral protective effect of propofol and sevoflurane combined with sufentanil anesthesia in the patients undergoing valvular surgery under cardiopulmonary bypass (CPB). Methods Sixty American Society of Anesthesiologists physical status Ⅱ or Ⅲ patients, aged 60-70 yr, scheduled for elective valvular surgery under CPB, were randomly divided into either propofol-based anesthesia group (group PA) or sevoflurane-based anesthesia group (group SA) , with 30 patients in each group. From induction of anesthesia to the end of surgery, group P received target- controlled infusion of propofol 0.5-2.0 μg/ml, and group S continuously inhaled 0.5%-2.5% sevoflurane. Bispectral index value was maintained at 45-55. Immediately after induction (T0) , at the end of surgery (T1 ) , and at 6, 12 and 24 h after surgery (T2-4) , the superior vena cava was retrogradely cannulated for blood sampling, and the concentrations of plasma S-100β protein and neuron-specific enzyme were determined using enzyme-linked immunosorbent assay. Results Compared with group SA, the plasma S- 100β concentrations at T1,2 and neuron-specific enzyme concentrations at T1-3 were significantly decreased in group PA. Conclusion The cerebral protective effect of propofol combined with sufentanil anesthesia is superior to that of sevoflurane combined with sufentanil anesthesia in the patients undergoing valvular surgery under CPB.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2015年第7期855-857,共3页 Chinese Journal of Anesthesiology
基金 中国博士后科学基金(2013M530880) 天津市卫生行业重点攻关项目(12KG125)
关键词 二异丙酚 舒芬太尼 麻醉药 吸入 心肺转流术 脑损伤 Propofol Sufentanil Anesthetics,inhalation Cardiopulmonary bypass Brain injuries
  • 相关文献

参考文献8

  • 1Dabrowski W, Rzeckl Z, Pilat J, et al. Brain damage in cardiac surgery patients[ J]. Curr Opin Pharmacol, 2012,12(2) : 189-194.
  • 2Wilcox ME, Charbonney E, d'Empaire PP, et al. Oral neutro- phils are an independent marker of the systemic inflammatory re- sponse after cardiac bypass[J]. J Inflamm(Lond),2014,11(1) :32.
  • 3Sun X, Lindsay J, Monsein LH, et al. Silent brain injury after cardiac surgery[J]. J Am Coll Cardiol,2012,60(9) :791-787.
  • 4胡义凤,殷政,胡毅平.七氟烷与丙泊酚麻醉对心内直视手术患者炎性反应的影响[J].实用医学杂志,2014,30(18):2994-2996. 被引量:7
  • 5王永旺,喻文立,薛玉良,翁亦齐,石屹崴,王刚,李津源,杜洪印.体外循环旁路洗入七氟醚对冠状动脉旁路移植术患者心肌炎性反应的影响[J].中华麻醉学杂志,2013,33(10):1185-1187. 被引量:4
  • 6Gtiqltl Y, lnver S, Aydmh B, et al. The effect of sevoflurane vs. TIVA on cerebral oxygen saturation during cardiopulmonary bypass-randomized trial[ J ]. Adv Clin Exp Med, 2014,23 (6) : 9199 -24.
  • 7Jovic M, Stancic A, Nenadic D, et al. Mitochondrial molecular basis of sevoflurane and propofol cardioprotection in pa- tients undergoing aortic valve replacement with cardiopulmonary bypass[ J]. Cell Physio! Biochem ,2012,29(1-2) : 131-142.
  • 8Bailey DM, Evans KA, McEneny J, et al. Exercise-induced oxidative-nitrosative stress is associated with impaired dynamic cerebral autoregulation and blood-brain barrier leakage[ J]. Exp Physiol,2011,96(11) : 1196-1207.

二级参考文献16

  • 1李军,洪梅,潘铁成.体外循环中炎症因子释放对单核细胞促凝活性的影响[J].中华实验外科杂志,2006,23(11):1331-1333. 被引量:5
  • 2Fleisher LA, Beckman JA, Brown KA, et M. ACC/AHA 2007 Guidelines on Perioperative Cardiovascular Evaluation and Care for- Noncardiac Surgery:Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guide- lines on Perioperative Cardiovascular Evaluation for NoncardiacSurg- ery) Developed in Collaboration With the American Society of Echo- cardiography, AmericanSociety of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Car- diovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. J Am Coil Cardiol, 2007,50(17) : 1707-1732.
  • 3Vinten-Johansen J. Involvement of neutrophils in the pathogenesis of lethal myocardial reperfusion injury. Cardiovasc Res, 2004, 61 (3): 481-497.
  • 4De Hert SG, Van der Linden PJ, Cromheecke S, et al. Cardiopro- tective properties of sevoflurane in patients undergoing coronary sur- gery with cardiopulmonary bypass are related to the modalities of its administration. Anesthesiology, 2004, 101(2):299-310.
  • 5Wu AH, Lu QA, Todd J, et al. Short- and long-term biological vari- ation in cardiac troponin I measured with a high-sensitivity assay: im- plications for clinical practice. Clinical Chemistry, 2009, 55 ( 1 ) : 52-58.
  • 6Kukielka GL, Smith CW, Manning AM, et al. Induction of interleu- kin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation, 1995, 92(7): 1866-1875.
  • 7Luo Y, Wang Y, Poynter JA, et al. Pretreating mesenchymal stem cells with interleukin-l3 and transforming growth factor- synergisti- cally increases vascular endothelial growth factor production and im- proves mesenchymal stem cells-mediated myocardial protection after acute ischemia. Surgery, 2012,151 (3) : 353-363.
  • 8Xiong XQ, Lin LN, Wang LR, et al. Sevoflurane attenuates pulmo- nary inflammation and ventilator-induced lung injury by upregulation of HO-1 mRNA expression in mice. Int J Nanomedicine, 2013, 6: 1075-1081.
  • 9Wang C, Xie H, Liu X, et al. Role of nuclear factor-roB in volatile anaesthetic preconditioning with sevoflurane during myocardial isch- aemia/reperfusion. Eur J Anaesthesiol, 2010, 27(8): 747-756.
  • 10Yu JB, Gong LR, Wang J, et al. Effect of sevoflurane combination with epidural anesthesia on myocardial injury in patients with coronary artery disease undergoing non-cardiac surgery[J]. Saudi Med J, 2011, 32( 10): 1009-1016.

共引文献9

同被引文献97

引证文献12

二级引证文献49

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部